MK MEDICAL
0897.997.492 · rovalta.com · 25/09/2026
MK MEDICAL
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOMK MEDICAL is a Private company with limited liability incorporated in 2008. Its registered office is in Charleroi.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0897.997.492
- Incorporation
- 19/05/2008
- Legal form
- Private company with limited liability
- Registered office
- Rue du Masy 58
6040 Charleroi · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 16 filingsTrend over 16 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 384,9 k € | +15.6% | 332,9 k € | +6.7% | 312 k € | +0.7% | 309,9 k € | +5.2% | 294,7 k € |
| EBITDA | 379,4 k € | +17.1% | 323,9 k € | +6.1% | 305,4 k € | -0.4% | 306,5 k € | +6.6% | 287,6 k € |
| Operating result | 378,2 k € | +17.2% | 322,7 k € | +12.2% | 287,6 k € | -0.7% | 289,8 k € | +7.1% | 270,7 k € |
| Net result | 248,6 k € | +14.5% | 217,1 k € | +8.3% | 200,6 k € | -0.1% | 200,7 k € | +4.8% | 191,5 k € |
| Balance sheet | |||||||||
| Equity | 1,4 M € | +19.7% | 1,2 M € | +17.5% | 981,8 k € | +18.8% | 826,2 k € | +23.2% | 670,5 k € |
| Total assets | 1,7 M € | +8.7% | 1,5 M € | +13.6% | 1,3 M € | +12.9% | 1,2 M € | +4.6% | 1,1 M € |
| Cash | 19,8 k € | +53.8% | 12,9 k € | +42.1% | 9,1 k € | +80.6% | 5 k € | -85.0% | 33,5 k € |
| Debts | 267,6 k € | -26.5% | 364 k € | +2.6% | 354,7 k € | -0.7% | 357,2 k € | -22.4% | 460,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/09/2025 | 07/10/2024 | 29/08/2023 | 18/10/2022 | 30/08/2021 | 14/11/2020 |
| General meeting | 31/07/2025 | 20/06/2024 | 15/06/2023 | 16/06/2022 | 17/06/2021 | 18/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 31/07/2025 | 29/09/2025 | French | |
| Micro model | 31/12/2023 | 20/06/2024 | 07/10/2024 | French | |
| Micro model | 31/12/2022 | 15/06/2023 | 29/08/2023 | French | |
| Micro model | 31/12/2021 | 16/06/2022 | 18/10/2022 | French | |
| Micro model | 31/12/2020 | 17/06/2021 | 30/08/2021 | French | |
| Micro model | 31/12/2019 | 18/06/2020 | 14/11/2020 | French | |
| Micro model | 31/12/2018 | 20/06/2019 | 26/11/2019 | French | |
| Micro model | 31/12/2017 | 21/12/2018 | 26/12/2018 | French | |
| Micro model | 31/12/2016 | 24/04/2017 | 07/06/2017 | French | |
| Abridged model | 31/12/2015 | 04/10/2016 | 31/10/2016 | French | |
| Abridged model | 31/12/2014 | 26/11/2015 | 30/11/2015 | French | |
| Abridged model | 31/12/2012 | 25/01/2014 | 22/03/2015 | French | |
| Abridged model | 31/12/2011 | 15/11/2013 | 17/04/2014 | French | |
| Abridged model | 31/12/2010 | 15/11/2013 | 17/04/2014 | French | |
| Abridged model | 31/12/2009 | 19/12/2012 | 13/12/2013 | French | |
| Abridged model | 31/12/2008 | 18/06/2009 | 14/02/2011 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024248,6 k €↑
- 2023Annual accounts 2023217,1 k €↑
- 2022Annual accounts 2022200,6 k €↓
- 2021Annual accounts 2021200,7 k €↑
- 2020Annual accounts 2020191,5 k €↓
- 2019Annual accounts 2019210,5 k €↑
- 2018Annual accounts 2018174,6 k €↑
- 2017Annual accounts 2017132,4 k €↑
- 2016Annual accounts 2016333,9 €↓
- 2015Annual accounts 201570,6 k €↑
- 2014Annual accounts 201422,3 k €↑
- 2012Annual accounts 20129,5 k €↓
- 2011Annual accounts 201130,8 k €↓
- 2010Annual accounts 201076,7 k €↑
- 2009Annual accounts 2009-3,5 k €↓
- 2008Annual accounts 200829,2 k €
- 19/05/2008IncorporationPrivate company with limited liability